Bruno Loi

1.3k total citations
22 papers, 178 citations indexed

About

Bruno Loi is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruno Loi has authored 22 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruno Loi's work include Coronary Interventions and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (6 papers) and Acute Myocardial Infarction Research (6 papers). Bruno Loi is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (6 papers) and Acute Myocardial Infarction Research (6 papers). Bruno Loi collaborates with scholars based in Italy, Netherlands and United States. Bruno Loi's co-authors include Alberto Boi, Bernardo Cortese, Giuseppe Steffenino, Alfonso Ielasi, Jasjit S. Suri, John R. Laird, Aditya Sharma, Ankush D. Jamthikar, Attilio Varricchio and Marco Sesana and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and The American Journal of Cardiology.

In The Last Decade

Bruno Loi

19 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Loi Italy 7 123 110 59 40 21 22 178
Pedro Azcárate Spain 11 80 0.7× 147 1.3× 19 0.3× 44 1.1× 26 1.2× 32 221
David M. Mego United States 10 130 1.1× 107 1.0× 68 1.2× 52 1.3× 18 0.9× 26 201
Antonio Totaro Italy 8 50 0.4× 165 1.5× 35 0.6× 47 1.2× 9 0.4× 34 199
Mauro Pennone Italy 8 76 0.6× 100 0.9× 38 0.6× 47 1.2× 9 0.4× 16 140
C Papadopoulos Greece 7 64 0.5× 245 2.2× 49 0.8× 53 1.3× 16 0.8× 13 272
Francesco Colombo Italy 9 122 1.0× 134 1.2× 36 0.6× 65 1.6× 19 0.9× 16 206
Marta Belmonte Italy 8 95 0.8× 169 1.5× 22 0.4× 131 3.3× 21 1.0× 36 222
Mozhgan Parsaee Iran 8 71 0.6× 174 1.6× 37 0.6× 56 1.4× 12 0.6× 52 239
Naohiko Kawaguchi Japan 11 153 1.2× 315 2.9× 68 1.2× 99 2.5× 30 1.4× 26 424
Kenichiro Saka Japan 5 144 1.2× 79 0.7× 75 1.3× 96 2.4× 11 0.5× 8 239

Countries citing papers authored by Bruno Loi

Since Specialization
Citations

This map shows the geographic impact of Bruno Loi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Loi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Loi more than expected).

Fields of papers citing papers by Bruno Loi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Loi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Loi. The network helps show where Bruno Loi may publish in the future.

Co-authorship network of co-authors of Bruno Loi

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Loi. A scholar is included among the top collaborators of Bruno Loi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Loi. Bruno Loi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pighi, Michele, Fabrizio Tomai, Simone Fezzi, et al.. (2024). Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART). Clinical Research in Cardiology. 113(7). 1017–1029.
2.
Wiebe, Jens, Nick E.J. West, Andreas Baumbach, et al.. (2021). Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium. Catheterization and Cardiovascular Interventions. 99(3). 533–540. 1 indexed citations
4.
Boi, Alberto, et al.. (2020). Mitro‐aortic fibrosa pseudoaneurysm and concomitant aortic stenosis: How to kill two birds with a stone. Journal of Cardiac Surgery. 35(9). 2414–2417. 3 indexed citations
5.
Loi, Bruno, et al.. (2020). Appropriateness of metformin prescription for type 2 diabetes mellitus patients with chronic kidney disease (Stages 3-5).. PubMed. 42(1). 71–76. 2 indexed citations
6.
Deidda, Martino, Cristina Piras, Alberto Boi, et al.. (2019). Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state. Scientific Reports. 9(1). 312–312. 11 indexed citations
7.
Carlo, Marco De, Luca Testa, Ferdinando Varbella, et al.. (2019). Two-year clinical outcomes of the “Italian diffuse/multivessel disease absorb prospective registry” (IT-DISAPPEARS). International Journal of Cardiology. 290. 21–26. 1 indexed citations
8.
Ielasi, Alfonso, Bernardo Cortese, Elisabetta Moscarella, et al.. (2018). One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry). EuroIntervention. 14(5). e546–e553. 5 indexed citations
9.
Boi, Alberto, et al.. (2018). Exclusion of a giant saphenous vein graft pseudo-aneurysm with a “double-layer bridging” technique. Cardiovascular revascularization medicine. 19(8). 8–12. 1 indexed citations
10.
Tarantini, Giuseppe, Giulia Masiero, Valeria Paradies, et al.. (2018). Absorb bioresorbable vascular scaffold vs. everolimus‐eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD‐ABSORB studies. Catheterization and Cardiovascular Interventions. 92(2). E115–E124. 5 indexed citations
11.
Boi, Alberto, Ankush D. Jamthikar, Luca Saba, et al.. (2018). A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography. Current Atherosclerosis Reports. 20(7). 33–33. 49 indexed citations
13.
Cortese, Bernardo, Alfonso Ielasi, Elisabetta Moscarella, et al.. (2017). Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry). The American Journal of Cardiology. 119(12). 1924–1930. 7 indexed citations
14.
Masiero, Giulia, Marco Mojoli, Valeria Paradies, et al.. (2017). TCT-9 Absorb Bioresorbable Vascular Scaffold vs. Everolimus-eluting Metallic Stent in Small Vessel Disease: a Propensity Matched Analysis of COMPARE II, RAI and MAASSTAD-ABSORB Prospective Studies. Journal of the American College of Cardiology. 70(18). B4–B4.
15.
Testa, Luca, Marco De Carlo, Ferdinando Varbella, et al.. (2017). One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS). EuroIntervention. 13(4). 424–431. 11 indexed citations
17.
Cortese, Bernardo, Alfonso Ielasi, Enrico Romagnoli, et al.. (2015). Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions. The American Journal of Cardiology. 116(5). 705–710. 31 indexed citations
18.
Pighi, Michele, Fabrizio Tomai, Leonardo De Luca, et al.. (2015). Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study. Journal of Cardiovascular Translational Research. 9(1). 40–48. 6 indexed citations
20.
Porcu, Michele, et al.. (1990). [Coronary artery dissection secondary to selective coronary angiography].. PubMed. 79(3). 175–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026